Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

New Drugs Treat Advanced Stages of a Common Skin Cancer
WSJ Pharmalot
Tuesday, November 25, 2014 - 10:58am
tags:
basal cell carcinoma, Erivedge, Genentech
Priority review period for Novartis cancer drug extended
Seeking Alpha
Tuesday, November 25, 2014 - 9:57am
tags:
Novartis, Multiple Myeloma, panobinostat, bortezomib
More Medicine Goes Off Limits in Drug-Price Showdown
Bloomberg
Tuesday, November 25, 2014 - 9:55am
tags:
drug pricing, Express Scripts
Novartis Dismisses Employee who Fabricated Data in Research Papers
WSJ Pharmalot
Tuesday, November 25, 2014 - 9:53am
tags:
Novartis
Bayer Said to Explore Sale of $2.5 Billion Diabetes Unit
Bloomberg
Tuesday, November 25, 2014 - 9:51am
tags:
Bayer, M&A, diabetes, Zoetis
Actavis Plans Job Cuts, China Expansion for Allergan
Bloomberg
Tuesday, November 25, 2014 - 9:40am
tags:
Actavis, Allergan, M&A, layoffs, China
Roche's Genentech defends supply shift for top cancer drugs
Yahoo/Reuters
Tuesday, November 25, 2014 - 9:37am
tags:
Roche, Genentech, cancer, Avastin, Herceptin, Rituxan, distribution
Smith & Nephew Still Entices as Regulators Loom: Real M&A
Bloomberg
Tuesday, November 25, 2014 - 9:36am
tags:
Smith & Nephew, M&A, Stryker, devices
Can Partnering To Fight Hepatitis C Pay At Enanta?
Investors.com
Monday, November 24, 2014 - 6:23pm
tags:
hepatitis C, Enanta, paritaprevir
Five Prime gets $30M upfront from Bristol-Myers and will study combination cancer treatment
Yahoo/AP
Monday, November 24, 2014 - 6:03pm
tags:
Five Prime, Bristol-Myers Squibb, Opdivo, FPA008, melanoma
AstraZeneca Loses Bid to End ‘Pay-For-Delay’ Nexium Trial
Bloomberg
Monday, November 24, 2014 - 12:47pm
tags:
AstraZeneca, Ranbaxy, Nexium, generics, pay-for-delay
Arena's Smoking Cessation, Nash, Combination Belviq-Phentermine and Free Belviq Samples
Seeking Alpha
Monday, November 24, 2014 - 11:39am
tags:
Arena Pharmaceuticals, smoking cessation, NASH, Belviq-Phentermine, samples
FDA tightens guidelines on technique for uterine fibroid surgery
Yahoo/Reuters
Monday, November 24, 2014 - 11:27am
tags:
FDA, uterine fibroids, devices, Ethicon, JNJ, laparoscopic power morcellators
Tufts study: it takes eight drugs in clinical trials to get one approval ​
Bizjournals.com
Monday, November 24, 2014 - 10:55am
tags:
clinical trials, drug approvals
FirstWord Lists – Pharma's fastest growing drugs
First Word Pharma
Monday, November 24, 2014 - 10:54am
tags:
prescription data
Galena, Shunned by Wall Street, Forced to Seek Pricey Vulture Financing
TheStreet.com
Monday, November 24, 2014 - 10:49am
tags:
Galena Biopharma
Enanta Pharmaceuticals beats 4Q profit forecasts
Yahoo/AP
Monday, November 24, 2014 - 10:19am
tags:
Enanta Pharmaceuticals, earnings
Amgen scraps trials of drug for advanced stomach cancer
Yahoo/Reuters
Monday, November 24, 2014 - 10:15am
tags:
Amgen, stomach cancer, rilotumumab
[video]Actavis-Allergan: Anatomy of a $66B Deal
Bloomberg
Monday, November 24, 2014 - 10:14am
tags:
Actavis, Allergan, M&A
Stryker Said to Weigh Bid for U.K.’s Smith & Nephew
Bloomberg
Monday, November 24, 2014 - 10:13am
tags:
Stryker, Smith & Nephew, devices, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.